IFP Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.94M | Sell |
50,426
-2,519
| -5% | -$203K | 0.07% | 305 |
|
|
2026
Q1 | $4.59M | Sell |
52,945
-4,342
| -8% | -$416K | 0.1% | 236 |
|
|
2025
Q4 | $5.5M | Buy |
57,287
+14,359
| +33% | +$1.39M | 0.12% | 177 |
|
|
2025
Q3 | $4.09M | Sell |
42,928
-507
| -1% | -$46.6K | 0.11% | 204 |
|
|
2025
Q2 | $3.79M | Buy |
43,435
+839
| +2% | +$71.2K | 0.11% | 202 |
|
|
2025
Q1 | $3.83M | Buy |
42,596
+7,310
| +21% | +$654K | 0.12% | 197 |
|
|
2024
Q4 | $2.82M | Buy |
35,286
+24,924
| +241% | +$2.16M | 0.09% | 247 |
|
|
2024
Q3 | $933K | Sell |
10,362
-926
| -8% | -$77.9K | 0.03% | 499 |
|
|
2024
Q2 | $888K | Buy |
11,288
+959
| +9% | +$78.6K | 0.04% | 476 |
|
|
2024
Q1 | $900K | Sell |
10,329
-1,272
| -11% | -$109K | 0.04% | 431 |
|
|
2023
Q4 | $955K | Sell |
11,601
-3,644
| -24% | -$278K | 0.05% | 393 |
|
|
2023
Q3 | $1.19M | Sell |
15,245
-4,987
| -25% | -$417K | 0.05% | 348 |
|
|
2023
Q2 | $1.78M | Buy |
20,232
+1,988
| +11% | +$171K | 0.07% | 279 |
|
|
2023
Q1 | $1.46M | Sell |
18,244
-18,331
| -50% | -$1.49M | 0.06% | 294 |
|
|
2022
Q4 | $2.97M | Buy |
36,575
+360
| +1% | +$29.2K | 0.08% | 257 |
|
|
2022
Q3 | $2.94M | Buy |
36,215
+3,986
| +12% | +$358K | 0.08% | 284 |
|
|
2022
Q2 | $2.62M | Hold |
32,229
| – | – | 0.08% | 277 |
|
|
2022
Q1 | $2.62M | Buy |
32,229
+23,350
| +263% | +$2.47M | 0.08% | 277 |
|
|
2021
Q4 | $919K | Buy |
8,879
+1,317
| +17% | +$153K | 0.02% | 423 |
|
|
2021
Q3 | $955K | Buy |
7,562
+44
| +0.6% | +$5.7K | 0.02% | 414 |
|
|
2021
Q2 | $928K | Sell |
7,518
-7,332
| -49% | -$921K | 0.02% | 389 |
|
|
2021
Q1 | $1.76M | Buy |
14,850
+1,293
| +10% | +$152K | 0.03% | 247 |
|
|
2020
Q4 | $1.59M | Sell |
13,557
-1,513
| -10% | -$167K | 0.06% | 248 |
|
|
2020
Q3 | $1.56M | Buy |
15,070
+578
| +4% | +$58K | 0.09% | 210 |
|
|
2020
Q2 | $1.31M | Sell |
14,492
-720
| -5% | -$69K | 0.1% | 206 |
|
|
2020
Q1 | $1.4M | Buy |
15,212
+1,336
| +10% | +$142K | 0.14% | 164 |
|
|
2019
Q4 | $1.57M | Sell |
13,876
-1,975
| -12% | -$217K | 0.12% | 201 |
|
|
2019
Q3 | $1.7M | Buy |
+15,851
| New | +$1.65M | 0.11% | 205 |
|
|
2019
Q1 | $304K | Sell |
3,346
-15,315
| -82% | -$1.37M | 0.04% | 374 |
|
|
2018
Q4 | $1.67M | Sell |
18,661
-259
| -1% | -$24.2K | 0.1% | 221 |
|
|
2018
Q3 | $1.86M | Buy |
18,920
+3,738
| +25% | +$346K | 0.08% | 277 |
|
|
2018
Q2 | $1.3M | Sell |
15,182
-876
| -5% | -$73.2K | 0.05% | 342 |
|
|
2018
Q1 | $1.3M | Hold |
16,058
| – | – | 0.06% | 325 |
|
|
2017
Q4 | $1.3M | Sell |
16,058
-4,544
| -22% | -$364K | 0.06% | 326 |
|
|
2017
Q3 | $1.6M | Sell |
20,602
-223
| -1% | -$18.5K | 0.06% | 314 |
|
|
2017
Q2 | $1.85M | Sell |
20,825
-1,669
| -7% | -$141K | 0.08% | 283 |
|
|
2017
Q1 | $1.81M | Sell |
22,494
-1,005
| -4% | -$78.5K | 0.08% | 274 |
|
|
2016
Q4 | $1.67M | Buy |
23,499
+1,244
| +6% | +$97.7K | 0.08% | 270 |
|
|
2016
Q3 | $1.92M | Sell |
22,255
-212
| -0.9% | -$18.5K | 0.1% | 229 |
|
|
2016
Q2 | $1.95M | Buy |
22,467
+19,121
| +571% | +$1.55M | 0.11% | 214 |
|
|
2016
Q1 | $304K | Sell |
3,346
-14,815
| -82% | -$1.12M | 0.04% | 374 |
|
|
2015
Q4 | $1.4M | Buy |
+18,161
| New | +$1.37M | 0.09% | 234 |
|
Other funds holding MDT
IFP Advisors's MDT Position: Q2 2026 in Review
IFP Advisors reduced its Medtronic (MDT) stake by 4.8% in Q2 2026, selling an estimated $203K and leaving 50,426 shares worth $3.94M. The position accounts for 0.07% of the portfolio, ranked #305.
IFP Advisors first reported a position in MDT in Q4 2015 and has held it in 42 quarters since. The position peaked at $5.5M in Q4 2025. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- IFP Advisors held 50,426 shares of Medtronic worth $3.94M as of Q2 2026.
- IFP Advisors sold 2,519 Medtronic shares in Q2 2026, an estimated $203K.
- Medtronic made up 0.07% of IFP Advisors's portfolio in Q2 2026, its #305 holding.
- IFP Advisors first reported a position in Medtronic in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Medtronic position peaked at $5.5M in Q4 2025.
- 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.